RxDoctor Payments Data

Michael Hibbs

Nurse Practitioner · Clarksville, TNNPI 1174712541

Payments from drug & device makers

$625in general payments, 2019–2025

Across 27 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$148
  • Exact Sciences$116
  • AbbVie$116
  • Axsome Therapeutics, Inc.$104
  • Novartis$63
  • AstraZeneca$32
  • plus $46 from 2 others

What the payments were for

  • Food & beverage$625100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$625 in reported general payments places this provider in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$34,453
Medicare patients
146
Services billed
560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate31$49,979
EliquisApixaban32$33,733
XareltoRivaroxaban39$33,113
TrulicityDulaglutide17$22,670
FarxigaDapagliflozin Propanediol21$18,660
OzempicSemaglutide17$15,508
JardianceEmpagliflozin11$11,126
GlyxambiEmpagliflozin/Linagliptin12$7,214
LantusInsulin Glargine,hum.Rec.Anlog17$3,394
Lantus SolostarInsulin Glargine,hum.Rec.Anlog29$3,070
Atorvastatin Calcium268$2,877
Novolog FlexpenInsulin Aspart18$2,417
Albuterol Sulfate HfaAlbuterol Sulfate67$2,220
Rosuvastatin Calcium171$1,772
Diltiazem 24hr Er (Cd)Diltiazem Hcl34$1,763

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$32$18,66021 claims
Novo NordiskOzempic$148$15,50817 claims
AbbVieSynthroid$116$1,13216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Clarksville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →